149 related articles for article (PubMed ID: 37084802)
1. The use of specific antihypertensive medication and skin cancer risk: A systematic review of the literature and meta-analysis.
Heisel AGU; Vuurboom MD; Daams JG; de Rie MA; Vogt L; van den Born BH; Olde Engberink RHG
Vascul Pharmacol; 2023 Jun; 150():107173. PubMed ID: 37084802
[TBL] [Abstract][Full Text] [Related]
2. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis.
Gandini S; Palli D; Spadola G; Bendinelli B; Cocorocchio E; Stanganelli I; Miligi L; Masala G; Caini S
Crit Rev Oncol Hematol; 2018 Feb; 122():1-9. PubMed ID: 29458778
[TBL] [Abstract][Full Text] [Related]
3. Associations of thiazide use with skin cancers: a systematic review and meta-analysis.
Shao SC; Lai CC; Chen YH; Lai EC; Hung MJ; Chi CC
BMC Med; 2022 Jul; 20(1):228. PubMed ID: 35794547
[TBL] [Abstract][Full Text] [Related]
4. Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study.
Pottegård A; Pedersen SA; Schmidt SAJ; Lee CN; Hsu CK; Liao TC; Shao SC; Lai EC
Br J Cancer; 2019 Nov; 121(11):973-978. PubMed ID: 31673105
[TBL] [Abstract][Full Text] [Related]
5. Photosensitizing antihypertensive medication and risk of skin cancer among postmenopausal women.
Hou A; Li Y; Shadyab AH; Han J; Eaton CB; Qureshi A; Cho E
J Dtsch Dermatol Ges; 2024 Feb; 22(2):186-194. PubMed ID: 38345266
[TBL] [Abstract][Full Text] [Related]
6. Is there a Link between Non Melanoma Skin Cancer and Hydrochlorothiazide?
Gallelli L; Cione E; Siniscalchi A; Vasta G; Guerra A; Scaramuzzino A; Longo L; Muraca L; De Sarro G; G Sp Working Group ; Leuzzi G; Gerace A; Scuteri A; Vasapollo P; Natale V; Zampogna S; Luciani F
Curr Drug Saf; 2022; 17(3):211-216. PubMed ID: 34732119
[TBL] [Abstract][Full Text] [Related]
7. [Hydrochlorothiazide and skin cancer].
Olde Engberink RHG; van der Hoeven NV; Zwinderman AH; van den Born BH
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120217
[TBL] [Abstract][Full Text] [Related]
8. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.
Pedersen SA; Gaist D; Schmidt SAJ; Hölmich LR; Friis S; Pottegård A
J Am Acad Dermatol; 2018 Apr; 78(4):673-681.e9. PubMed ID: 29217346
[TBL] [Abstract][Full Text] [Related]
9. Skin Cancer and Hydrochlorothiazide: Novel Population-Based Analyses Considering Personal Risk Factors Including Race/Ethnicity.
Birck MG; Moura CS; Machado MAA; Liu JL; Abrahamowicz M; Pilote L; Bernatsky S
Hypertension; 2023 Oct; 80(10):2218-2225. PubMed ID: 37489540
[TBL] [Abstract][Full Text] [Related]
10. Importance of accounting for timing of time-varying exposures in association studies: Hydrochlorothiazide and non-melanoma skin cancer.
Danieli C; Moura CS; Pilote L; Bernatsky S; Abrahamowicz M
Pharmacoepidemiol Drug Saf; 2023 Dec; 32(12):1411-1420. PubMed ID: 37528702
[TBL] [Abstract][Full Text] [Related]
11. Hydrochlorothiazide use and risk of keratinocyte carcinoma and melanoma: A multisite population-based cohort study.
Azoulay L; St-Jean A; Dahl M; Quail J; Aibibula W; Brophy JM; Chan AW; Bresee L; Carney G; Eltonsy S; Tamim H; Paterson JM; Platt RW;
J Am Acad Dermatol; 2023 Aug; 89(2):243-253. PubMed ID: 37105517
[TBL] [Abstract][Full Text] [Related]
12. Use of Antihypertensive Drugs and Risk of Malignant Melanoma: A Meta-analysis of Observational Studies.
Tang H; Fu S; Zhai S; Song Y; Han J
Drug Saf; 2018 Feb; 41(2):161-169. PubMed ID: 28905299
[TBL] [Abstract][Full Text] [Related]
13. Photoinduced skin reactions of cardiovascular drugs-a systematic review.
Götzinger F; Reichrath J; Millenaar D; Lauder L; Meyer MR; Böhm M; Mahfoud F
Eur Heart J Cardiovasc Pharmacother; 2022 Jun; 8(4):420-430. PubMed ID: 35278085
[TBL] [Abstract][Full Text] [Related]
14. Hydrochlorothiazide treatment and risk of non-melanoma skin cancer: Review of the literature.
Garrido PM; Borges-Costa J
Rev Port Cardiol (Engl Ed); 2020 Mar; 39(3):163-170. PubMed ID: 32354458
[TBL] [Abstract][Full Text] [Related]
15. Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data.
Kim JC; Kim YC; Choi JW
Clin Exp Dermatol; 2021 Jun; 46(4):680-686. PubMed ID: 33215728
[TBL] [Abstract][Full Text] [Related]
16. Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study.
Drucker AM; Hollestein L; Na Y; Weinstock MA; Li WQ; Abdel-Qadir H; Chan AW
CMAJ; 2021 Apr; 193(15):E508-E516. PubMed ID: 33846199
[TBL] [Abstract][Full Text] [Related]
17. Hydrochlorothiazide and the risk of skin cancer. A scientific statement of the British and Irish Hypertension Society.
Faconti L; Ferro A; Webb AJ; Cruickshank JK; Chowienczyk PJ;
J Hum Hypertens; 2019 Apr; 33(4):257-258. PubMed ID: 30842544
[No Abstract] [Full Text] [Related]
18. Telmisartan/hydrochlorothiazide-induced nevus-associated cutaneous melanoma: first report in the medical literature.
Tchernev G; Patterson JW
Expert Rev Clin Pharmacol; 2021 Mar; 14(3):289-293. PubMed ID: 33576302
[No Abstract] [Full Text] [Related]
19. Superior antihypertensive and cardioprotective effects of chlorthalidone compared with hydrochlorothiazide.
Chrysant SG; Chrysant GS
Drugs Today (Barc); 2021 Apr; 57(4):291-301. PubMed ID: 33851692
[TBL] [Abstract][Full Text] [Related]
20. Thiazide diuretics alone or in combination with a potassium-sparing diuretic on blood pressure-lowering in patients with primary hypertension: protocol for a systematic review and network meta-analysis.
Martins VM; Ziegelmann PK; Helal L; Ferrari F; Lucca MB; Fuchs SC; Fuchs FD
Syst Rev; 2022 Feb; 11(1):23. PubMed ID: 35135630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]